Bill Wexler's Dog Pound Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Bill Wexler's Dog Pound

REFR 1.560

-2.5%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike M who wrote (2142)	7/14/1999 12:45:00 PM
From: Hank	Read Replies (2) of 10293

Here'some more info. on VHPM's pleconaril that most of you are probably not aware of. Pleconaril did NOT originate with VPHM. It is a drug that has been under development for at least 8 years (perhaps much longer) and was originally discovered by scientists at Sterling Winthrop Pharmaceuticals (most of whom now work for VPHM). Sterling Winthrop was a small drug company owned by Kodak. In 1994, Kodak sold off Sterling Winthrop in bits and pieces and the prescription drug business was bought by Sanofi, a french drug maker. Sanofi had dibs on pleconaril but decided to out license it to former Sterling scientists when they decided to form VPHM because they were obviously not impressed with it's potential as a drug. However, I would be surprised if Sanofi didn't still have some licensing rights to any profits that may result from pleconaril, if it gets approved. I'll have to look through VPHM's SEC filings to see if this is true.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next